Form 4: Applied Therapeutics CFO Sells Shares to Cover Tax Obligations

Leslie D. Funtleyder, CFO of Applied Therapeutics, sold 28,727 shares of common stock to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• On March 14, 2024, Leslie D. Funtleyder, the Chief Financial Officer of Applied Therapeutics, Inc. (APLT), sold 28,727 shares of the company's common stock.
• The shares were sold at a weighted average price of $5.39.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
• Following the transaction, Funtleyder directly owns 308,421 shares of Applied Therapeutics.
• The sale was not a discretionary transaction but rather a 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations, which is a neutral event. It doesn't necessarily reflect a positive or negative sentiment towards the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares could have a minor, temporary impact on the stock price, but it is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates